Answers are grounded in this paper and cite their sources.
Purpose: To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods: Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. Results: The patients showed an interruption of the functional losses and remained stable with semestral injections. Conclusion: AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.
No takes yet. Share an insight, caveat, or question.
Bordin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: